David W. Cragg
Net Worth

Last updated:

What is David W. Cragg net worth?

The estimated net worth of Mr. David W. Cragg is at least $14,638,502 as of 9 Nov 2021. He owns shares worth $5,366,458 as insider, has earned $2,237,484 from insider trading and has received compensation worth at least $7,034,560 in Cytokinetics, Incorporated.

What is the salary of David W. Cragg?

Mr. David W. Cragg salary is $541,120 per year as Chief HR & Admin. Officer in Cytokinetics, Incorporated.

How old is David W. Cragg?

Mr. David W. Cragg is 69 years old, born in 1956.

What stocks does David W. Cragg currently own?

As insider, Mr. David W. Cragg owns shares in one company:

Company Title Shares Price per share Total value
Cytokinetics, Incorporated (CYTK) Chief HR & Admin. Officer 138,704 $38.69 $5,366,458

What does Cytokinetics, Incorporated do?

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK logo
CYTK
Cytokinetics, Incorporated
$38.69

David W. Cragg insider trading

Cytokinetics, Incorporated

Mr. David W. Cragg has made 7 insider trades between 2012-2021, according to the Form 4 filled with the SEC. Most recently he sold 20,481 units of CYTK stock worth $855,287 on 9 Nov 2021.

The largest trade he's ever made was exercising 62,500 units of CYTK stock on 4 Sep 2012. As of 9 Nov 2021 he still owns at least 138,704 units of CYTK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 20,481 $41.76 $855,287
Option
Common Stock 45,000 $9.65 $434,250
Option
Non-Qualified Stock Option (right to buy) 49,038 $9.65 $473,217
Option
Non-Qualified Stock Option (right to buy) 13,350 $6 $80,100
Option
Common Stock 25,000 $6 $150,000
Sale
Common Stock 18,325 $34.89 $639,359
Sale
Common Stock 7,569 $35.14 $265,990
Sale
Common Stock 7,850 $32.78 $257,315
Sale
Common Stock 2,616 $29.67 $77,617
Sale
Common Stock 6,013 N/A N/A
Option
Incentive Stock Option (right to buy) 8,437 $6.3 $53,153
Option
Common Stock 14,999 $13.96 $209,446
Sale
Common Stock 6,562 $21.63 $141,916
Option
Non-Qualified Stock Option (right to buy) 16,666 $9.42 $156,994
Option
Common Stock 16,666 $9.42 $156,994
Option
Common Stock 10,416 N/A N/A
Option
Restricted Stock Units 10,416 N/A N/A
Option
Common Stock 62,500 $1.05 $65,625
Option
Restricted Stock Units 62,500 $1.05 $65,625

Cytokinetics, Incorporated key executives

Cytokinetics, Incorporated executives and other stock owners filed with the SEC: